{
    "2020-10-12": [
        [
            {
                "time": "",
                "original_text": "健帆生物：前三季度预计净利润同比增长40.0%~60.0%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "前三季",
                        "净利润",
                        "同比增长",
                        "40.0%-60.0%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：前三季净利预增40%-60%",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529.SZ",
                        "前三季",
                        "净利",
                        "预增",
                        "40%-60%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物现1笔大宗交易 共成交1,238.98万元",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "大宗交易",
                        "1笔",
                        "成交",
                        "1,238.98万元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}